John Hamilton, LMFT, LADC

President/CEO
Liberation Programs, Inc.

Presently President and CEO of Liberation Programs, a behavioral health agency in Connecticut.
John currently Chairs the advisory board for the Connecticut Department of Mental Health and Addiction Services (DMHAS) and serves on the Governors Alcohol and Drug Policy Council. John was the 2013 recipient of the Nyswander-Dole Award. John received his B.S. degree in Psychology in 1981 from Marist College and his Master’s Degree in Marriage and Family Therapy in 1986.
Full Bio:
John Hamilton re-joined Liberation Programs in 2018, having served as the agency’s
Vice President of Clinical Services and Senior Vice President from 1996-2006.
He is nationally recognized as an expert in the field of addiction treatment and prevention,
and brings three decades of experience to his role as President and Chief Executive Officer.
John chairs the advisory board for the Connecticut Department of Mental Health and
Addiction Services (DMHAS) and serves on the Governors Alcohol and Drug Policy Council.
Previously, John was the Chief Clinical Outreach Officer at Mountainside Treatment Center,
a nationally acclaimed drug rehabilitation center with locations in New York and Connecticut.
He served as the Chief Executive Officer of Recovery Network of Programs, a non-profit
behavioral health agency serving the Greater Bridgeport Community. John is Past Chair
of the Dissemination Committee for the National Institute for Drug Abuse (NIDA) Clinical
Trials Network, Past Chair of the Community Treatment Providers Caucus, Past President
of the Southwest Connecticut Mental Health Board, Past President of the New England
Association of Drug Court Professionals, and co-Founder of the Greenwich Father’s Forum.
He has consulted for NIDA and the Substance Abuse and Mental Health Service
Administration (SAMHSA).
In 2013, John was the recipient of the American Association for the Treatment of Opioid
Dependence (AATOD) Nyswander-Dole Award for his contributions to the field of Addiction
Treatment.

Presentation(s):

Visit the aatod conference website for more details…www.aatodconference.com.

@aatod1984
  • #aatod2024 ➡️ www.aatodconference.com
  • “Buon giorno, bon jour, buenas dias, goedemorgen, boker tov, dobro utro, godan daginn, bom dia, dobro jutro, god morgon. Just a few ways to say good morning at AATOD Las Vegas. Our international colleagues are making their plans to attend, and now you have many ways to say hello. So, break out your Babel and Rosetta Stone and practice, practice, practice. A warm and friendly greeting is always welcome and a great conversation starter.” - Michael Rizzi

💻 Conference video message #aatod2024 International Chair ➡️ bit.ly/3wjz5sf
  • ✅ Final Reminder 

🏨 TODAY is the AATOD Room Block Reservation Deadline - Tuesday, April 30, 2024

💻 Book Your Stay for the #aatod2024 Conference ➡️ bit.ly/3wpsj45

📝 NOTE: The 2024 AATOD Conference will be held at the Planet Hollywood Resort and Casino but all sleeping rooms are soldout. Therefore, AATOD has secured an overflow block of rooms at a discounted rate allocated for AATOD conference attendees at the Paris Las Vegas Hotel and Casino, the OFFICIAL 2024 AATOD Conference Overflow Block. The negotiated rate includes a waived resort fee. These rates will be available, based on availability, until Tuesday, April 30, 2024. The government rate will not be offered within the AATOD block of rooms at the Paris Las Vegas Hotel and Casino.
  • Standard Registration Deadline:
TOMORROW - Tuesday, April 30, 2024

Don't miss out on the chance to attend the AATOD 2024 Conference, �the world's premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024

Register ➡️ aatodconference.com
  • AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
  • View the latest #aatod2024 Conference Video Message from the Host Committee Chair, Katro Henderson. 

We look forward to seeing you next month in Las Vegas for the world’s premier training conference event for the Treatment of Opioid Use Disorder. #OUD #somuchmorethanmedication

https://youtu.be/i6u3qUS95jU
  • 💻 Access the 3/27 SAMHSA Webinar Recording on 42 CFR Part 8, Clinical ➡️ bit.ly/3TIEZdW.

#ICYMI This comprehensive webinar provided an overview of the rule changes and provided a discussion with SAMHSA regarding the implications of the changes.
  • 💻 Webinar Recording is Now Available
AATOD is pleased to share the March 20th SAMHSA Webinar Recording on 42 CFR Part 8, Administrative.  We encourage you to view this recording to assist you in determining how you will need to prepare for full implementation of these regulations. 

➡ https://youtu.be/pgWZUpDhi94?si=obomo4LXRIwJPiC8
  • 3/28 Expanding Access to #Methadone in Correctional Facilities will focus on opportunities to expand access to methadone in correctional facilities, including recent developments with the SAMHSA 2024 final rule on the use of methadone.

Register ➡️ bit.ly/3Vz1RPE
  • Invitation to SAMHSA Webinars on 42 CFR Part 8 💻 

On February 2, 2024, the final rule for 42 CFR Part 8 was published. The effective date for these regulations is April 2, 2024, with an implementation date of October 2, 2024. 

In preparation for implementation of the revisions, SAMHSA will provide two preliminary webinars for OTPs.  The first will focus on administrative areas; the second will focus more on clinical content. These will be held on March 20th (from 2-3pm EST) and March 27th, 2024 (from 2- 3pm EST).  

REGISTER ➡ https://conta.cc/3TF9CSQ

View the final rule ➡ https://lnkd.in/e_iu-AtG.

There will be an opportunity to receive an overview of the rule changes and discuss with SAMHSA the implications of the changes. 

We encourage you to attend these important meetings to assist you in determining how you will need to prepare for full implementation of these regulations. 

This webinar series will be moderated by Mark W. Parrino, MPA (AATOD President). Speakers include Yngvild Olsen, MD, MPH (Director - CSAT), Robert Baillieu, MD, MPH, FAAFP (Physician and Senior Advisor - SAMHSA/CSAT, and Patti Juliana, PhD, LCSW
(Director - CSAT’s Division of Pharmacologic Therapies).

The presentations will be followed by Q&A, and these webinars will become available to the public for On-Demand viewing via the AATOD website. Certificates of Attendance will be provided per request.
#aatod2024 ➡️ www.aatodconference.com
#aatod2024 ➡️ www.aatodconference.com
16 hours ago
View on Instagram |
1/10
“Buon giorno, bon jour, buenas dias, goedemorgen, boker tov, dobro utro, godan daginn, bom dia, dobro jutro, god morgon. Just a few ways to say good morning at AATOD Las Vegas. Our international colleagues are making their plans to attend, and now you have many ways to say hello. So, break out your Babel and Rosetta Stone and practice, practice, practice. A warm and friendly greeting is always welcome and a great conversation starter.” - Michael Rizzi

💻 Conference video message #aatod2024 International Chair ➡️ bit.ly/3wjz5sf
“Buon giorno, bon jour, buenas dias, goedemorgen, boker tov, dobro utro, godan daginn, bom dia, dobro jutro, god morgon. Just a few ways to say good morning at AATOD Las Vegas. Our international colleagues are making their plans to attend, and now you have many ways to say hello. So, break out your Babel and Rosetta Stone and practice, practice, practice. A warm and friendly greeting is always welcome and a great conversation starter.” - Michael Rizzi 💻 Conference video message #aatod2024 International Chair ➡️ bit.ly/3wjz5sf
1 day ago
View on Instagram |
2/10
✅ Final Reminder 

🏨 TODAY is the AATOD Room Block Reservation Deadline - Tuesday, April 30, 2024

💻 Book Your Stay for the #aatod2024 Conference ➡️ bit.ly/3wpsj45

📝 NOTE: The 2024 AATOD Conference will be held at the Planet Hollywood Resort and Casino but all sleeping rooms are soldout. Therefore, AATOD has secured an overflow block of rooms at a discounted rate allocated for AATOD conference attendees at the Paris Las Vegas Hotel and Casino, the OFFICIAL 2024 AATOD Conference Overflow Block. The negotiated rate includes a waived resort fee. These rates will be available, based on availability, until Tuesday, April 30, 2024. The government rate will not be offered within the AATOD block of rooms at the Paris Las Vegas Hotel and Casino.
✅ Final Reminder 🏨 TODAY is the AATOD Room Block Reservation Deadline - Tuesday, April 30, 2024 💻 Book Your Stay for the #aatod2024 Conference ➡️ bit.ly/3wpsj45 📝 NOTE: The 2024 AATOD Conference will be held at the Planet Hollywood Resort and Casino but all sleeping rooms are soldout. Therefore, AATOD has secured an overflow block of rooms at a discounted rate allocated for AATOD conference attendees at the Paris Las Vegas Hotel and Casino, the OFFICIAL 2024 AATOD Conference Overflow Block. The negotiated rate includes a waived resort fee. These rates will be available, based on availability, until Tuesday, April 30, 2024. The government rate will not be offered within the AATOD block of rooms at the Paris Las Vegas Hotel and Casino.
2 days ago
View on Instagram |
3/10
Standard Registration Deadline:
TOMORROW - Tuesday, April 30, 2024

Don't miss out on the chance to attend the AATOD 2024 Conference, �the world's premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024

Register ➡️ aatodconference.com
Standard Registration Deadline: TOMORROW - Tuesday, April 30, 2024 Don't miss out on the chance to attend the AATOD 2024 Conference, �the world's premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024 Register ➡️ aatodconference.com
2 days ago
View on Instagram |
4/10
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️  TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations. We certainly hope that this is helpful and please let us know if you have any questions.
2 weeks ago
View on Instagram |
5/10
View the latest #aatod2024 Conference Video Message from the Host Committee Chair, Katro Henderson. 

We look forward to seeing you next month in Las Vegas for the world’s premier training conference event for the Treatment of Opioid Use Disorder. #OUD #somuchmorethanmedication

https://youtu.be/i6u3qUS95jU
View the latest #aatod2024 Conference Video Message from the Host Committee Chair, Katro Henderson. We look forward to seeing you next month in Las Vegas for the world’s premier training conference event for the Treatment of Opioid Use Disorder. #OUD #somuchmorethanmedication https://youtu.be/i6u3qUS95jU
3 weeks ago
View on Instagram |
6/10
💻 Access the 3/27 SAMHSA Webinar Recording on 42 CFR Part 8, Clinical ➡️ bit.ly/3TIEZdW.

#ICYMI This comprehensive webinar provided an overview of the rule changes and provided a discussion with SAMHSA regarding the implications of the changes.
💻 Access the 3/27 SAMHSA Webinar Recording on 42 CFR Part 8, Clinical ➡️ bit.ly/3TIEZdW. #ICYMI This comprehensive webinar provided an overview of the rule changes and provided a discussion with SAMHSA regarding the implications of the changes.
3 weeks ago
View on Instagram |
7/10
💻 Webinar Recording is Now Available
AATOD is pleased to share the March 20th SAMHSA Webinar Recording on 42 CFR Part 8, Administrative.  We encourage you to view this recording to assist you in determining how you will need to prepare for full implementation of these regulations. 

➡ https://youtu.be/pgWZUpDhi94?si=obomo4LXRIwJPiC8
💻 Webinar Recording is Now Available AATOD is pleased to share the March 20th SAMHSA Webinar Recording on 42 CFR Part 8, Administrative. We encourage you to view this recording to assist you in determining how you will need to prepare for full implementation of these regulations. ➡ https://youtu.be/pgWZUpDhi94?si=obomo4LXRIwJPiC8
4 weeks ago
View on Instagram |
8/10
3/28 Expanding Access to #Methadone in Correctional Facilities will focus on opportunities to expand access to methadone in correctional facilities, including recent developments with the SAMHSA 2024 final rule on the use of methadone.

Register ➡️ bit.ly/3Vz1RPE
3/28 Expanding Access to #Methadone in Correctional Facilities will focus on opportunities to expand access to methadone in correctional facilities, including recent developments with the SAMHSA 2024 final rule on the use of methadone. Register ➡️ bit.ly/3Vz1RPE
1 month ago
View on Instagram |
9/10
Invitation to SAMHSA Webinars on 42 CFR Part 8 💻 

On February 2, 2024, the final rule for 42 CFR Part 8 was published. The effective date for these regulations is April 2, 2024, with an implementation date of October 2, 2024. 

In preparation for implementation of the revisions, SAMHSA will provide two preliminary webinars for OTPs.  The first will focus on administrative areas; the second will focus more on clinical content. These will be held on March 20th (from 2-3pm EST) and March 27th, 2024 (from 2- 3pm EST).  

REGISTER ➡ https://conta.cc/3TF9CSQ

View the final rule ➡ https://lnkd.in/e_iu-AtG.

There will be an opportunity to receive an overview of the rule changes and discuss with SAMHSA the implications of the changes. 

We encourage you to attend these important meetings to assist you in determining how you will need to prepare for full implementation of these regulations. 

This webinar series will be moderated by Mark W. Parrino, MPA (AATOD President). Speakers include Yngvild Olsen, MD, MPH (Director - CSAT), Robert Baillieu, MD, MPH, FAAFP (Physician and Senior Advisor - SAMHSA/CSAT, and Patti Juliana, PhD, LCSW
(Director - CSAT’s Division of Pharmacologic Therapies).

The presentations will be followed by Q&A, and these webinars will become available to the public for On-Demand viewing via the AATOD website. Certificates of Attendance will be provided per request.
Invitation to SAMHSA Webinars on 42 CFR Part 8 💻 On February 2, 2024, the final rule for 42 CFR Part 8 was published. The effective date for these regulations is April 2, 2024, with an implementation date of October 2, 2024. In preparation for implementation of the revisions, SAMHSA will provide two preliminary webinars for OTPs.  The first will focus on administrative areas; the second will focus more on clinical content. These will be held on March 20th (from 2-3pm EST) and March 27th, 2024 (from 2- 3pm EST).  REGISTER ➡ https://conta.cc/3TF9CSQ View the final rule ➡ https://lnkd.in/e_iu-AtG. There will be an opportunity to receive an overview of the rule changes and discuss with SAMHSA the implications of the changes. We encourage you to attend these important meetings to assist you in determining how you will need to prepare for full implementation of these regulations. This webinar series will be moderated by Mark W. Parrino, MPA (AATOD President). Speakers include Yngvild Olsen, MD, MPH (Director - CSAT), Robert Baillieu, MD, MPH, FAAFP (Physician and Senior Advisor - SAMHSA/CSAT, and Patti Juliana, PhD, LCSW (Director - CSAT’s Division of Pharmacologic Therapies). The presentations will be followed by Q&A, and these webinars will become available to the public for On-Demand viewing via the AATOD website. Certificates of Attendance will be provided per request.
1 month ago
View on Instagram |
10/10

AVAILABLE 🗒️ TECHNICAL REVIEW OF @SAMHSA’S FINAL REGS ➡️ http://bit.ly/3w71hOM
This brief can be used by treatment providers/state officials as a quick reference in better understanding the salient policy issues in the new regs. We hope that this is helpful.

Load More...

#aatod2024 Conference – Las Vegas

COUNTDOWN

2024 Conference

AATOD, Inc.
225 Varick Street, Suite 402
New York, New York 10014

Contact Us
Phone : 212-566-5555
Email : info@aatod.org

Social Sharing
RSS
Follow by Email
Facebook
Twitter
YouTube
LinkedIn
Instagram
Stay Connected to AATOD